Laboratoires Euromedis specializes in the design, manufacturing and distribution of medical equipment intended primarily for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals. The products include gloves (No. 1 in France in disposable medical gloves), surgical items (sensors, pockets, scalpels, etc.), hygiene and protection equipment (white-coats, masks, shoes, etc.), parenteral approaches (needles, syringes, transfusion equipment, etc.), diagnostic products, etc.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	14.56M 16.7M 13.49M 12.63M 23.68M 1.58B 23.82M 160M 62.01M 776M 62.69M 61.35M 2.69B	P/E 2024	-2.05x	P/E 2025	-84.9x
Enterprise Value	4M 4.58M 3.7M 3.47M 6.5M 433M 6.54M 43.92M 17.02M 213M 17.21M 16.84M 739M	EV / Sales 2024	0.57x	EV / Sales 2025	0.01x
Free-Float	34.87%	Yield 2024 *	-	Yield 2025	-

04-30	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01/11/25	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025	CI
05/05/25	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25/10/24	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2024	CI
31/10/23	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2023	CI
28/04/23	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2022	CI
30/09/22	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2022	CI
29/04/22	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2021	CI
30/09/21	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2021	CI
08/07/21	Euromedis Groupe : Malaysia rubber glove body pleads for go-ahead to restart factories	RE
26/04/21	Global markets live: Philips, Crédit Suisse, Nestlé...
23/04/21	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2020	CI
24/09/20	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2020	CI

31/10/25	LABORATOIRES EUROMEDIS : RAPPORT FINANCIER SEMESTRIEL 2025	PU
31/10/25	Laboratoires Euromedis : Euromedis - Communiqué semestriel 2025	PU
10/12/24	LABORATOIRES EUROMEDIS : Ajustement du contrat de liquidité	PU
26/04/24	Laboratoires Euromedis : Euromedis - Communiqué résultat 2023	PU
30/09/22	EUROMEDIS : Rapport Financier semestriel 2022	PU

06-19	Agenda des dividendes et des AG de la semaine : session dividendes pour la galaxie Bolloré
05-06	LABORATOIRES EUROMEDIS : RAPPORT FINANCIER ANNUEL 2025
05-06	LABORATOIRES EUROMEDIS : Fin du contrat de liquidité
04-24	Laboratoires Euromedis : Communiqué résultat 2025
04-24	Laboratoires Euromedis : Résultats 2025 (7. Laboratoires Euromedis Communiqu e de presse r sultat 2025 v23.04.26)

Director	Title	Age	Since
Mathieu Roturier CHM	Chairman	49	26/11/2019
Francky Défossé BRD	Director/Board Member	39	-
Joseph Asselin BRD	Director/Board Member	52	08/03/2017

EUROMEDIS Stock Swiss Exchange

Stocks

OXEUMD

FR0000075343

Medical Equipment, Supplies & Distribution

Valuation: EUROMEDIS

Latest news : EUROMEDIS

Press Releases: EUROMEDIS

News in other languages: EUROMEDIS

Managers and Directors: EUROMEDIS

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EUROMEDIS	-.--%	-.--%	-	-	16.7M
ABBOTT LABORATORIES	-0.56%	-1.13%	-34.21%	-19.01%	154B
MEDTRONIC PLC	-0.64%	-1.79%	-8.17%	-9.69%	102B
HOYA CORPORATION	-0.99%	+2.10%	+59.76%	+56.65%	56.51B
CENCORA, INC.	+0.02%	-3.37%	-7.23%	+44.75%	52.89B
BECTON, DICKINSON AND COMPANY	-1.30%	-2.32%	-16.24%	-44.92%	39.67B
MEDLINE INC.	-0.99%	-5.30%	-	-	30.39B
DEXCOM, INC.	-4.01%	-6.45%	-13.03%	-45.12%	27.96B
WEST PHARMACEUTICAL SERVICES, INC.	-0.32%	-1.23%	+51.06%	-11.21%	23.17B
TERUMO CORPORATION	+0.90%	+2.05%	-14.45%	-4.79%	20.35B
Average	-0.79%	-1.30%	+2.19%	-4.17%	56.28B
Weighted average by Cap.	-0.77%	-1.24%	-6.77%	-3.66%

	2024	2025
Net sales	36.41M 41.76M 33.72M 31.57M 59.2M 3.94B 59.56M 400M 155M 1.94B 157M 153M 6.73B	41.06M 47.1M 38.03M 35.6M 66.77M 4.44B 67.17M 451M 175M 2.19B 177M 173M 7.59B
Net income	-6.11M -7.01M -5.66M -5.3M -9.93M -661M -9.99M -67.11M -26.01M -325M -26.3M -25.73M -1.13B	-132K -151K -122K -114K -214K -14.26M -216K -1.45M -561K -7.02M -567K -555K -24.37M
Net Debt	8.04M 9.22M 7.44M 6.97M 13.07M 870M 13.15M 88.3M 34.22M 428M 34.6M 33.86M 1.49B	-10.57M -12.12M -9.78M -9.16M -17.18M -1.14B -17.28M -116M -44.99M -563M -45.48M -44.51M -1.95B